-
1
-
-
0019987597
-
Indication for use of hepatitis B vaccine, based on cost-effectiveness analysis
-
Mulley AG, Silverstein MD, Dientag JL. Indication for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med 1982; 307: 644-652.
-
(1982)
N Engl J Med
, vol.307
, pp. 644-652
-
-
Mulley, A.G.1
Silverstein, M.D.2
Dientag, J.L.3
-
2
-
-
0027513311
-
A re-appraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis
-
Bloom BS, Hillman AL, Frendrick MD, Schwartz JS. A re-appraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis. Ann Intern Med 1993; 118: 298-306.
-
(1993)
Ann Intern Med
, vol.118
, pp. 298-306
-
-
Bloom, B.S.1
Hillman, A.L.2
Frendrick, M.D.3
Schwartz, J.S.4
-
3
-
-
0027471994
-
Should Canada and the US universally vaccinate infants against Hepatitis B? A cost effectiveness analysis
-
Krahn M, Detsky AS. Should Canada and the US universally vaccinate infants against Hepatitis B? A cost effectiveness analysis. Med Decis Making, 1993; 13: 4-20.
-
(1993)
Med Decis Making
, vol.13
, pp. 4-20
-
-
Krahn, M.1
Detsky, A.S.2
-
4
-
-
0010923713
-
An economic evaluation of vaccination strategies against hepatitis B virus: Health care workers and homosexual men
-
Bethwaite JG, Bethwaite PB. An economic evaluation of vaccination strategies against hepatitis B virus: Health care workers and homosexual men. New Zealand Economic Papers 1991; 25: 19-38.
-
(1991)
New Zealand Economic Papers
, vol.25
, pp. 19-38
-
-
Bethwaite, J.G.1
Bethwaite, P.B.2
-
5
-
-
0021021373
-
The Markov process in medical prognosis
-
Beck, JR, Pauker SG. "The Markov process in medical prognosis" Med Decis Making 1983; 3: 419-458.
-
(1983)
Med Decis Making
, vol.3
, pp. 419-458
-
-
Beck, J.R.1
Pauker, S.G.2
-
10
-
-
0023184948
-
Chronic type hepatitis and the "healthy" HBsAg carrier state
-
Hoofnagle JH, Shafritz DA, Popper H. Chronic type hepatitis and the "healthy" HBsAg carrier state. Hepatology 1987; 7: 758-763.
-
(1987)
Hepatology
, vol.7
, pp. 758-763
-
-
Hoofnagle, J.H.1
Shafritz, D.A.2
Popper, H.3
-
11
-
-
0019451351
-
Hepatocellular carcinoma and the hepatitis B virus: A prospective study of 22707 men in Taiwan
-
Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and the hepatitis B virus: A prospective study of 22707 men in Taiwan. Lancet 1981; 21: 1129-1133.
-
(1981)
Lancet
, vol.21
, pp. 1129-1133
-
-
Beasley, R.P.1
Hwang, L.Y.2
Lin, C.C.3
Chien, C.S.4
-
12
-
-
0021751383
-
Survival in chronic hepatitis B: An analysis of 379 patients
-
Weissburg JE, Ljudevit AL, Coleman I et al. Survival in chronic hepatitis B: An analysis of 379 patients. Ann Intern Med 1984; 101: 613-616.
-
(1984)
Ann Intern Med
, vol.101
, pp. 613-616
-
-
Weissburg, J.E.1
Ljudevit, A.L.2
Coleman, I.3
-
13
-
-
0025062593
-
The changing epidemiology of hepatitis B in the United States
-
Alter MJ, Hadler SC, Margolis HS et al. The changing epidemiology of hepatitis B in the United States. JAMA 1990; 263: 1218-1222.
-
(1990)
JAMA
, vol.263
, pp. 1218-1222
-
-
Alter, M.J.1
Hadler, S.C.2
Margolis, H.S.3
-
15
-
-
0027322069
-
On what basis should health be discounted?
-
Olsen JA. On what basis should health be discounted? J Health Econ 1993; 12: 39-53.
-
(1993)
J Health Econ
, vol.12
, pp. 39-53
-
-
Olsen, J.A.1
-
16
-
-
0026278394
-
Developing the health care market
-
Maynard A. 'Developing the health care market'. The Economic Journal 1991; 101: 1277-86.
-
(1991)
The Economic Journal
, vol.101
, pp. 1277-1286
-
-
Maynard, A.1
|